Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

Authors: Stefan Hagel, Friedhelm Bach, Thorsten Brenner, Hendrik Bracht, Alexander Brinkmann, Thorsten Annecke, Andreas Hohn, Markus Weigand, Guido Michels, Stefan Kluge, Axel Nierhaus, Dominik Jarczak, Christina König, Dirk Weismann, Otto Frey, Dominic Witzke, Carsten Müller, Michael Bauer, Michael Kiehntopf, Sophie Neugebauer, Thomas Lehmann, Jason A. Roberts, Mathias W. Pletz, , Anke Braune, Karsten Schmidt, Johann Motsch, Nadine Pinder, Daniel Richter, Peter Schlattmann, Andreas Ameln-Mayerhofer von, Markus Schappacher, Thomas Fuchs, Anka Röhr, Max Kurlbaum, Oliver Schreiner, Lars Hüter, Matthias Gründling, Stefan Angermair, Maria Deja, Frank Bloos, Sandra Fiedler, Hicham Chkirni

Published: 2022-02-01

DOI: 10.1007/s00134-021-06609-6

Source: Full article


Abstract

No abstract found.